Previous 10 | Next 10 |
Summary Eli Lilly currently has a forward P/E of over 45x. This high valuation is much higher than the sector average. A pair trade between XPH and LLY is proposed. Introduction I give Eli Lilly ( LLY ) a sell rating. While I am bullish on the pharmaceutical space due ...
Summary The top two mega themes in terms of global net inflows in 2022 were Climate Change-related themes and Big Data. The largest net outflows came from tech-heavy themes, led by Robotics & Automation. 2023 may bring a return to more normal markets driven by economics rather t...
Summary Global business conditions worsened in the penultimate month of the year according to the JPMorgan Global Composite PMI, compiled by S&P Global. New order expansions were seen in merely three of the 21 sectors tracked by the global PMI - software & services, pharmaceutic...
Summary Expectations surrounding central bank policy, China’s gradual reopening and a lower US dollar are key to investor sentiment in the final stretch of 2022. Central banks have increased interest rates at the fastest rate on record, and there are signs that higher yields are ...
Summary Surging stocks show markets believe hopes of a soft landing by the Fed to be true. We disagree and stay underweight developed market (DM) stocks. U.S. stocks jumped and bond yields plunged after October CPI rose less than the market expected. But sticky core inflation keep...
Summary U.S. midterm elections: Win, lose or draw for markets? What sectors may benefit from a divided government. Will equity markets get the post midterm election bump? For further details see: U.S. Midterm Elections: Win, Lose Or Draw For Markets? ...
Summary XPH invests in U.S. pharmaceuticals stocks. The fund is concentrated in 44 holdings. It is difficult to value the fund, as earnings are less transparent as compared to most other sectors, which I would argue deserves a higher average equity risk premium. On balance...
Summary Why the declines in tech on the S&P 500 may be hiding strength in other sectors from investors. The energy sector may still provide opportunities for investors. Insurers are not suffering the same challenges as other financials in the current high-rate environment....
Summary In today's issue of the 1-Minute Market Report, I examine the market bounce since the October low, and highlight the areas of the market that are leading the way higher. On Thursday, for every stock that was down, there were 26 that were up. For the first time since August...
Summary While a divided US government may look appealing, there are long-term risks amid resulting gridlock. The longest night belonged to the pollsters and pundits, whose predictions for a “red wave” did not come to fruition. Looking at historical relationships ...
News, Short Squeeze, Breakout and More Instantly...
SPDR S&P Pharmaceuticals Company Name:
XPH Stock Symbol:
NYSE Market:
Second Quarter 2024 Highlights: Record sales of $3.61 billion, up 18% in U.S. dollars and 11% organically compared to the second quarter of 2023 GAAP Diluted EPS of $0.41, up 11% compared to prior year Record Adjusted Diluted EPS of $0.44, up 22% compared to prior year ...
2024-07-19 12:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Transaction highlights: To acquire CommScope’s Outdoor Wireless Networks and Distributed Antenna Systems businesses for $2.1 billion in cash Adds advanced antenna and associated interconnect products, technologies and capabilities Complements Amphenol’s existing prod...